Zynfuse
Zynfuse
Pioneering titanium and composite implant systems designed to meet the rigorous clinical demands of Italy's premier cardiothoracic units.
An analysis of clinical workflows, macroeconomic changes, and the shift from wire cerclage to rigid sternal fixation across Italian healthcare networks.
In Italy, the Servizio Sanitario Nazionale (SSN) has steadily placed greater emphasis on clinical outcomes and hospital length-of-stay (LOS). Traditional wire cerclages, while cost-effective upfront, show higher rates of sternal dehiscence, deep sternal wound infections (DSWI), and mediastinitis—particularly in high-risk patients. Italian cardiothoracic units at major hubs such as the Ospedale Niguarda in Milan and the Policlinico Universitario Agostino Gemelli in Rome are increasingly adopting rigid plating systems to ensure construct stability, reduce post-operative pain, and lower secondary surgery costs.
Italy possesses one of the world's oldest populations. Consequently, patients undergoing median sternotomies for Coronary Artery Bypass Grafting (CABG) or valve replacements frequently present with comorbidities like osteoporosis, advanced diabetes, Chronic Obstructive Pulmonary Disease (COPD), and obesity. These patient profiles require sternal closure systems that distribute mechanical stress evenly. Grade 5 Titanium plates and dynamic locking screws offer the high fatigue strength needed to prevent bone cutting and mechanical failure under respiratory strain.
Navigating the stringent standards mandated by the European Medical Device Regulation for Class IIb and Class III surgical implants.
Exporting orthopedic and thoracic implants to Italy requires strict adherence to EU MDR guidelines. Our production processes are designed to provide complete traceability, comprehensive clinical evaluation portfolios, and systematic Post-Market Clinical Follow-up (PMCF) datasets. All sternal fixation plates, screws, and instruments carry valid CE validation.
We work closely with local authorized representatives (EC REP) to ensure all medical devices are registered in the *Repertorio dei Dispositivi Medici* (RDM) database overseen by the Italian Ministry of Health (*Ministero della Salute*). This registration is required for direct participation in public tenders (*Gare d'appalto*) across all regions.
Our raw materials, including pure Titanium (Grade 2/4) and Titanium Alloy (Ti-6Al-4V ELI conforming to ASTM F136), undergo rigorous biocompatibility validation (ISO 10993). Our manufacturing facilities run under a strict ISO 13485 certified quality management system, maintaining safety and cleanliness from initial machining to final sterilization packaging.
Leveraging state-of-the-art orthopedic engineering and global logistics networks to supply Italian surgical distributors.
Zynfuse Medical Technology Co., Ltd. is a professional orthopedic medical device manufacturer specializing in bone fusion and advanced implant systems for surgical innovation. With 12 years of industry experience and 7 years of export experience, we serve global healthcare markets with consistent quality and reliability.
Our client base primarily includes medical distributors, hospital procurement departments, and orthopedic surgical centers. We place a strong emphasis on quality control, implementing ISO 13485-based inspection systems, mechanical performance testing, and biocompatibility evaluations. Our product inspection methods include dimensional verification, fatigue testing, and surface integrity analysis.
With a robust R&D team of 85 engineers, Zynfuse continues to expand its innovation capabilities, launching approximately 320 new products annually. We offer extensive customization options, including implant geometry adjustment, material selection, and OEM/ODM solutions tailored to client needs. Our robust trade background ensures stable supply and consistent product excellence for Italian healthcare providers.
Every implant undergoes meticulous processing, CNC machining, surface finishing, and quality control steps to guarantee intraoperative performance.
How our streamlined production and logistics capabilities minimize lead times and maximize margins for medical device importers in Italy.
We understand that supply chain delays can impact surgical planning. By utilizing advanced ERP-driven production scheduling and maintaining stock profiles of core titanium plates and instrument kits, we ensure dispatch within agreed timelines. Shipments to major Italian logistics ports—including Genoa, Trieste, and Milan Malpensa—are coordinated through reliable logistics partners.
Different clinical teams have distinct structural preferences. Our R&D team collaborates with distributors to adjust plate profiles, screw thread pitches, and surface treatments. Whether adapting a custom contour plate for pectus excavatum corrections or customizing a trauma implant, Zynfuse provides rapid prototyping and validation.
By optimizing manufacturing footprints in our 18,600 m² facility and using Swiss-type CNC lathes, we offer competitive pricing models. This allows Italian importers and regional distributors to maintain healthy margins while remaining competitive in regional hospital tenders (*Gare regionali*).
High-rigidity sternal closure systems designed for high-risk patients and complex chest wall reconstructions.
Following a standard median sternotomy for coronary artery bypass graft procedures, sternal instability can lead to micro-motion and delayed bone healing. Our rigid locking plate system provides primary stabilization, allowing patients to participate in pulmonary rehabilitation and physical therapy earlier. This is especially beneficial for elderly patients in Italy's northern region healthcare networks (e.g., Lombardia and Veneto).
For pediatric and adult chest reconstructions, our Funnel Chest Orthopedic System offers customizable support bars and plates. The titanium construct provides structural support during the remodeling phase, maintaining excellent biocompatibility and high resistance to fatigue failure over years of implantation.
Beyond thoracic surgery, Zynfuse manufactures CE/ISO certified trauma implants, external fixators, and specialized surgical instrument sets.
Technical and commercial information for medical device procurement managers and hospital administrators in Italy.